SCHEMBL1995927

SCHEMBL1995927

CC(C)(C)CCc1ccccc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.39
FDPS P14324 1/20 0.39
CYP3A4 P08684 2/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RIPK1 Q13546 3/20 0.35
TDP1 Q9NUW8 2/20 0.34
TAAR1 Q96RJ0 1/20 0.34
NUDT1 P36639 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
ALDH1A1 P00352 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 1/20 0.32
ADRA2B P18089 1/20 0.32
PTGS1 P23219 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1259956 0.98 SIGMAR1 (0.38) SIGMAR1FDPSCYP3A4ALOX15CASP1
SCHEMBL5417529 0.79 SIGMAR1 (0.35) SIGMAR1FDPSCYP3A4ALOX15CASP1
SCHEMBL17778194 0.78 FDPS (0.39) SIGMAR1FDPSCYP3A4ALOX15CASP1
SCHEMBL234864 0.78 CYP3A4 (0.53) SIGMAR1FDPSCYP3A4ALOX15CASP1
SCHEMBL19140484 0.77 FDPS (0.40) SIGMAR1FDPSCYP3A4ALOX15CASP1
SCHEMBL1691505 0.77 FDPS (0.50) FDPSCYP3A4ALOX15CASP1CASP7
SCHEMBL3843060 0.76 SIGMAR1 (0.33) SIGMAR1FDPSALDH1A1
SCHEMBL618720 0.76 CYP1A2 (0.31) CYP3A4
SCHEMBL12561645 0.75 IDO1 (0.48) SLC6A2SLC6A4SLC6A3ALDH1A1POLB
SCHEMBL29443967 0.75 CYP3A4 (0.43) SIGMAR1FDPSCYP3A4ALOX15CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140213557-A1 Active Compound Combinations BAYER CROPSCIENCE AG (DE) 2014-07-31 US claimed
EP-2640707-B1 5-HALOGENOPYRAZOLECARBOXAMIDES BAYER IP GMBH (DE) 2017-03-15 EP disclosed
US-9414600-B2 Active compound combinations BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-08-16 US disclosed
US-9375004-B2 5-halogenopyrazolecarboxamides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-06-28 US disclosed
US-20140213557-A1 Active Compound Combinations BAYER CROPSCIENCE AG (DE) 2014-07-31 US disclosed
US-8754009-B2 Active compound combinations BAYER CROPSCIENCE AG (DE) 2014-06-17 US disclosed
US-20130296269-A1 5-Halogenopyrazolecarboxamides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-11-07 US disclosed
EP-2043995-B1 A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION BAYER CROPSCIENCE AG (DE) 2013-01-02 EP disclosed
EP-2043995-B1 A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION BAYER CROPSCIENCE AG (DE) 2013-01-02 EP disclosed
US-8071824-B2 Method for producing alkenylnitrobenzene derivatives unbranched in the 1′-position BAYER CROPSCIENCE AG (DE) 2011-12-06 US disclosed
US-20100076229-A1 Method for Producing Alkenylnitrobenzene Derivatives Unbranched in the 1'-Position BAYER CROPSCIENCE AG (DE) 2010-03-25 US disclosed
EP-2046720-A2 NITROBENZOL DERIVATIVES AND METHOD FOR PRODUCING SAID 1' ALKYLNITROBENZENES AND ALKYLANILINES Bayer CropScience Aktiengesellschaft (DE) 2009-04-15 EP disclosed
WO-2008006576-A1 A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION BAYER CROPSCIENCE AG (DE) 2008-01-17 WO disclosed
WO-2008006574-A2 NITROBENZOL DERIVATIVES AND METHOD FOR PRODUCING SAID 1' ALKYLNITROBENZENES AND ALKYLANILINES BAYER CROPSCIENCE AG (DE) 2008-01-17 WO disclosed
US-20070004921-A1 Isopentyl carboxanilides for combating undesired micro-organisms BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-01-04 US disclosed
US-20070004921-A1 Isopentyl carboxanilides for combating undesired micro-organisms BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-01-04 US disclosed
EP-1562595-A1 DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2005-08-17 EP disclosed
EP-1509225-A1 METHOD FOR THE USE OF PYRANOINDOLE DERIVATIVES TO TREAT INFECTION WITH HEPATITIS C VIRUS Wyeth (US) 2005-03-02 EP disclosed
WO-2004026305-A1 DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONIST ELI LILLY AND COMPANY (US) 2004-04-01 WO disclosed
WO-2003099275-A1 METHOD FOR THE USE OF PYRANOINDOLE DERIVATIVES TO TREAT INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2003-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213557-A1 Active Compound Combinations AGXT, GLUL, GMNN SIGMAR1 3314/4885FDPS 833/4885CYP3A4 1609/4885
US-20070004921-A1 Isopentyl carboxanilides for combating undesired micro-organisms MLYCD, MRPL21, PGLS SIGMAR1 418/4885FDPS 207/4885CYP3A4 1462/4885
US-20130296269-A1 5-Halogenopyrazolecarboxamides CYP3A5, CBR3, HDHD5 SIGMAR1 3101/4885FDPS 29/4885CYP3A4 20/4885
US-20100076229-A1 Method for Producing Alkenylnitrobenzene Derivatives Unbranched in the 1'-Position CYP1B1, AKR7A2, CYP1A1 SIGMAR1 2019/4885FDPS 276/4885CYP3A4 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.